3.1. Analysis.
Comparison 3 Anti‐T lymphocyte + methotrexate versus methotrexate, Outcome 1 Percentage change from baseline (QMT) at 12 months.
Comparison 3 Anti‐T lymphocyte + methotrexate versus methotrexate, Outcome 1 Percentage change from baseline (QMT) at 12 months.